Can a simple injection fade acne scars? new trial aims to find out

NCT ID NCT07058883

Recruiting now Symptom relief Sponsor: Nordberg Medical AB Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests Juläine, an injectable made from polylactic acid, to see if it can safely improve facial acne scars. About 55 adults with moderate to severe scars will receive either Juläine or a placebo (saline) over three sessions. Researchers will track changes in scar appearance and skin health for 12 months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Juläine (polylactic acid) injectable implant
What this could lead to: If it works, this could offer a safe, non-surgical option to reduce the appearance of acne scars and improve skin quality.
What could go wrong: This is an early-stage trial with only 55 people, so results may not apply to everyone. The placebo group may also show improvement, and long-term effects are unknown.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACNE SCARS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Acne Vulgaris

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ACNE SCARS

Contacts and locations

Locations

Centrum Medyczne dr Kubik
RECRUITING

Gdynia, Poland
Individual Specialist Medical Practice Maria Luiza-Piesiaków
RECRUITING

Gdansk, Poland

More trials for these conditions

Other studies related to the condition(s) this trial covers.